Lantheus Holdings (LNTH) Share-based Compensation Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) Share-based Compensation Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | -10.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.37% |
| Mar 31, 2026 | -33.74% |
| Dec 31, 2025 | 23.05% |
| Sep 30, 2025 | 20.30% |
| Jun 30, 2025 | 20.79% |
| Mar 31, 2025 | 21.98% |
| Dec 31, 2024 | -255.63% |
| Sep 30, 2024 | 45.72% |
| Jun 30, 2024 | 525.56% |
| Mar 31, 2024 | 100.87% |
| Dec 31, 2023 | -152.05% |
| Sep 30, 2023 | 72.48% |
| Jun 30, 2023 | -60.15% |
| Mar 31, 2023 | 75.64% |
| Dec 31, 2022 | 107.90% |
| Sep 30, 2022 | 109.54% |
| Jun 30, 2022 | 61.55% |
| Mar 31, 2022 | 244.22% |
| Dec 31, 2021 | 269.11% |
| Sep 30, 2021 | -3.13% |